We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current HUMA market cap is 597.83M. The company's latest EPS is USD -0.8802 and P/E is -12.45.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.73M | -24.62M | -26.18M | -26.58M | -29.5M |
| Net Income | -22.71M | -26M | -25.11M | -31.9M | -56.66M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.26M | 1.57M | 0 |
| Operating Income | -249k | -81.26M | -84.58M | -100.05M |
| Net Income | -233k | -26.48M | -11.97M | -110.78M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 168.11M | 149.39M | 128.22M | 161.47M | 138.28M |
| Total Liabilities | 106.99M | 112.39M | 114.68M | 135.31M | 166.57M |
| Total Equity | 61.12M | 36.99M | 13.55M | 26.15M | -28.29M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.26M | 286.53M | 204.3M | 128.22M |
| Total Liabilities | 2.1M | 164.36M | 87.37M | 114.68M |
| Total Equity | 5M | 122.17M | 116.93M | 13.55M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -41.24M | -54.25M | -73.31M | -27.35M | -48.64M |
| Investing | 470k | -23k | -173k | -391k | -575k |
| Financing | 5.61M | 4.84M | 4.51M | 62.8M | 62.33M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -245k | -81.19M | -71.13M | -73.31M |
| Investing | -100M | -8.22M | 4.85M | -173k |
| Financing | 101.34M | 266.98M | -1.45M | 4.51M |
| Market Cap | 597.83M |
| Price to Earnings Ratio | -12.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 17.15 |
| Price to Book Ratio | 101.83 |
| Dividend Yield | - |
| Shares Outstanding | 125.86M |
| Average Volume (1 week) | 3.28M |
| Average Volume (1 Month) | 2.7M |
| 52 Week Change | 59.93% |
| 52 Week High | 9.97 |
| 52 Week Low | 2.48 |
| Spread (Intraday) | 2.43 (39.84%) |
| Company Name | Humacyte Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.humacyte.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
